Literature DB >> 2156165

Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis.

P F Piguet1, M A Collart, G E Grau, A P Sappino, P Vassalli.   

Abstract

The deposition of silica particles in the lung of man or experimental animals leads to silicosis, a disease of progressive respiratory failure caused by a fibrotic reaction. It has long been suspected that the phagocytosis of silica by pulmonary macrophages induces the secretion of fibrogenic factors. Several potentially fibrogenic cytokines released by macrophages have been identified, including interleukin-1 (IL-1), tumour necrosis factor-alpha (TNF), platelet-derived growth factor, basic fibroblast growth factor and transforming growth factor-beta (TGF-beta). Here we show that TNF plays an important part in silica-induced pulmonary fibrosis in mice in that (1) a single instillation of silica leads to a marked increase in the level of lung TNF messenger RNA which lasts for greater than 70 days, while there are no obvious changes in the amounts of IL-1 alpha or TGF-beta mRNAs; and (2) silica-induced collagen deposition is almost completely prevented by anti-TNF antibody, but is significantly increased by continuous infusion of mouse recombinant TNF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156165     DOI: 10.1038/344245a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  139 in total

1.  Mitogenic activity for fibroblasts induced by silica and titanium dioxide particles in vitro and in vivo.

Authors:  R K Kumar; R O'Grady; W Li; G M Velan
Journal:  Int J Exp Pathol       Date:  1992-10       Impact factor: 1.925

2.  Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers.

Authors:  A Schmitt-Gräff; S Krüger; F Bochard; G Gabbiani; H Denk
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

Review 3.  Mechanisms of fibrosis: therapeutic translation for fibrotic disease.

Authors:  Thomas A Wynn; Thirumalai R Ramalingam
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

4.  Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.

Authors:  Elizabeth F Redente; Rebecca C Keith; William Janssen; Peter M Henson; Luis A Ortiz; Gregory P Downey; Donna L Bratton; David W H Riches
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

Review 5.  Cytokine polymorphisms in silicosis and other pneumoconioses.

Authors:  Berran Yucesoy; Val Vallyathan; Douglas P Landsittel; Petia Simeonova; Michael I Luster
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

6.  Effect of inhaled crystalline silica in a rat model: time course of pulmonary reactions.

Authors:  Vincent Castranova; Dale Porter; Lyndell Millecchia; Jane Y C Ma; Ann F Hubbs; Alexander Teass
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

7.  Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis.

Authors:  James C Bonner; Annette B Rice; Jennifer L Ingram; Cindy R Moomaw; Abraham Nyska; Alyce Bradbury; Alisha R Sessoms; Patricia C Chulada; Daniel L Morgan; Darryl C Zeldin; Robert Langenbach
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  IL-1beta augments TNF-alpha-mediated inflammatory responses from lung epithelial cells.

Authors:  Sara Saperstein; Linlin Chen; David Oakes; Gloria Pryhuber; Jacob Finkelstein
Journal:  J Interferon Cytokine Res       Date:  2009-05       Impact factor: 2.607

Review 9.  Host responses in tissue repair and fibrosis.

Authors:  Jeremy S Duffield; Mark Lupher; Victor J Thannickal; Thomas A Wynn
Journal:  Annu Rev Pathol       Date:  2012-10-22       Impact factor: 23.472

10.  Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa.

Authors:  D Gosselin; J DeSanctis; M Boulé; E Skamene; C Matouk; D Radzioch
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.